I’m pleased to share a comprehensive look at my career journey—from my early years in cardiothoracic surgery to my work in medical device innovation, clinical and regulatory leadership, and executive roles across both global corporations and early-stage ventures. My path has been driven by a passion for advancing medical technology and improving patient outcomes, and I remain committed to supporting the next generation of innovators. Here is my biography.

Arup Pramanik is a globally recognized healthcare executive who has spent 25 years transforming how innovation reaches patients. With deep expertise in market access, pricing strategy, and digital health, Arup has led major global initiatives across top pharmaceutical companies including Boehringer Ingelheim, Novartis, and Takeda. Known for uniting science with strategy, he has reshaped commercialization pathways through AI, real-world evidence, and value-based models—delivering outcomes that benefit both enterprise growth and health equity. Now preparing for board roles, Arup brings unmatched global insight, cross-sector leadership, and a bold vision for patient-centered innovation.

I’m passionate about transforming healthcare through ethical data innovation, strategic leadership, and empowering the next generation of women in tech and science. With over 20 years of experience in healthcare analytics, AI, and data governance, I’ve led global teams, shaped operational strategy, and served on advisory boards and nonprofit foundations. Whether through mentoring, publishing, or speaking on global stages, I’m committed to advancing equitable, data-driven solutions that improve lives and elevate leadership across industries.

I'm excited to share my professional biography, capturing the journey I've taken across HEOR, pharmaceutical innovation, real-world evidence, and health policy. With over 20 years of experience in building value through data, strategic insight, and collaborative leadership, I'm proud to continue this work alongside inspiring teams and partners.

Mary Cantu is a seasoned healthcare executive with over two decades of experience leading global market access, reimbursement strategy, and health policy across the medical device and pharmaceutical industries. Renowned for her ability to navigate complex regulatory and payer landscapes, she has successfully developed and executed comprehensive access strategies that drive product adoption, secure favorable coverage and coding, and expand patient access across domestic and international markets. With a proven track record of aligning cross-functional teams around clear, value-based goals, Mary brings strategic vision, operational excellence, and a deep commitment to healthcare innovation to every stage of the product lifecycle.

Patrick Speer is a purpose-driven healthcare executive with a strong track record of leading Medicare strategy, growth, and operations across some of the nation's most innovative health plans. With experience spanning finance, analytics, and executive leadership, he has consistently advanced Medicare Advantage, Dual Eligible, and Group Medicare products with a focus on improving outcomes and access for seniors. At the core of Patrick’s work is a deep commitment to simplifying healthcare and building systems that prioritize people, especially the most vulnerable. His leadership is grounded in data, driven by mission, and powered by a belief that better care starts with trust, clarity, and compassion.

Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.

As a passionate advocate for innovation and patient-centered care, I’ve dedicated my career to bridging medical, economic, and regulatory landscapes to drive impactful outcomes. My experience spans over 38 years in biotechnology and pharmaceutical industries, emphasizing payer engagement, HEOR, and lifecycle management. Here is my biography.

I am excited to share my professional journey as a health economist and healthcare strategist with over 17 years of global experience. My work focuses on aligning economic evaluation with innovative healthcare technologies to create sustainable solutions for public and private payers. Here is my biography.